Zinc dibutyldithiocarbamate API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Zinc dibutyldithiocarbamate API 136-23-2?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Zinc dibutyldithiocarbamate. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Zinc dibutyldithiocarbamate
- Synonyms:
- (T-4)-bis(dibutylcarbamodithioato-κS,κS')zinc , bis(dibutyldithiocarbamato)zinc , dibutyldithiocarbamate zinc salt , zinc bis(dibutyldithiocarbamate) , zinc bis(dibutyldithiocarbamoyl)disulfide , zinc bis(dibutyldithiocarbamoyl)disulphide , zinc bis(dibutylthiocarbamoyl)disulfide
- Cas Number:
- 136-23-2
- DrugBank number:
- DB14194
- Unique Ingredient Identifier:
- HNM5J934VP
General Description:
Zinc dibutyldithiocarbamate, identified by CAS number 136-23-2, is a notable compound with significant therapeutic applications. Zinc dibutyldithiocarbamate is a dermatological sensitizer and allergen. Sensitivity to zinc dibutyldithiocarbamate may be identified with a clinical patch test.
Indications:
This drug is primarily indicated for: Zinc dibutyldithiocarbamate is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years of age and older. Its use in specific medical scenarios underscores its importance in the therapeutic landscape.
Categories:
Zinc dibutyldithiocarbamate is categorized under the following therapeutic classes: Acids, Acyclic, Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Carbamates, Cell-mediated Immunity, Increased Histamine Release, Metal cations, Metal divalent cations, Standardized Chemical Allergen, Sulfur Compounds, Vasoprotectives, Zinc Compounds. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Zinc dibutyldithiocarbamate is a type of Antidotes, Deterrents, and Toxicologic Agents
Antidotes, Deterrents, and Toxicologic Agents are an important category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that play a critical role in healthcare and toxicology. These substances are designed to counteract the effects of poisons, toxins, and overdoses, thereby saving lives and preventing severe health consequences.
Antidotes are substances that neutralize the toxic effects of certain drugs, chemicals, or poisons. They work by either directly binding to the toxic substance or by blocking its harmful actions on the body. Antidotes are administered in emergency situations to quickly reverse the effects of poisoning and restore normal physiological functions.
Deterrents, on the other hand, are pharmaceutical agents used to discourage or prevent harmful behaviors, such as substance abuse. They are designed to make the ingestion or misuse of certain substances unpleasant or less desirable. Deterrents can be formulated to cause unpleasant side effects, such as nausea or vomiting, when a particular substance is consumed in excessive amounts.
Toxicologic agents encompass a broad range of pharmaceutical APIs used in toxicology studies and research. These substances are employed to investigate the toxicity, metabolism, and mechanisms of action of various chemicals and compounds. Toxicologic agents are vital for understanding the potential hazards and risks associated with certain substances, ensuring the safety of drugs, and developing effective treatments for poisoning cases.
In conclusion, Antidotes, Deterrents, and Toxicologic Agents are essential categories of pharmaceutical APIs that address poisoning emergencies, deter harmful behaviors, and enable toxicological research. Their development and availability are crucial for safeguarding public health, enhancing patient care, and advancing our understanding of toxicology.
